Concepedia

J. Y. Han

JY

10

Publications

523

Citations

10

H-Index

2004

Active since

Affiliations

National Cancer Center(Current)

Samsung Medical Center

Sungkyunkwan University

Seoul National University Hospital

Guangdong Academy of Medical Sciences

J. Y. Han is an author at National Cancer Center specializing in medicine, pharmacotherapy, and oncology.

ORCID

Top concepts

Publications per year

2004–2018

10

Publications

10

Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study

Vassiliki A. Papadimitrakopoulou, Yi‐Long Wu, J. Y. Han et al. · Annals of Oncology · 2018 · 250 citations

, , +6

A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer

Yong Sang Hong, Si Young Song, S. I. Lee et al. · Annals of Oncology · 2004 · 124 citations · Full text

, , +7

1300: Efficacy and safety of BI 1482694 (HM61713), an EGFR mutant-specific inhibitor, in T790M-positive NSCLC at the recommended phase II dose

K. Park, J.-S. Lee, J. Y. Han et al. · Journal of Thoracic Oncology · 2016 · 38 citations · Full text

, , +9

AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)

Caicun Zhou, M. Wang, Ying Cheng et al. · Annals of Oncology · 2018 · 21 citations · Full text

Measurement of Long-Range Near-Side Two-Particle Angular Correlations in p p Collisions at √s = 13 TeV

V. Khachatryan, A. M. Sirunyan, A. Tumasyan et al. · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 2016 · 19 citations · Full text

Rows per page

1–5 of 10